Welcome to our dedicated page for EUDA Health Holdings Ordinary Shares news (Ticker: $EUDA), a resource for investors and traders seeking the latest updates and insights on EUDA Health Holdings Ordinary Shares stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect EUDA Health Holdings Ordinary Shares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of EUDA Health Holdings Ordinary Shares's position in the market.
EUDA Health Holdings has successfully completed the acquisition of CK Health Plus Sdn Bhd, expanding its presence in Malaysia and venturing into direct selling of holistic wellness products in Southeast Asia. The acquisition provides EUDA with access to CK Health's distribution network, customer base, and industry expertise, enhancing its regional market position and product portfolio.
EUDA Health Holdings (EUDA) announced the acquisition of CK Health Plus Sdn Bhd, a direct seller of holistic wellness products in Malaysia, for 10 million shares valued at US$15 million. The deal is set to close on 8th May 2024. CK Health's products focus on non-invasive therapies and exclusive distribution rights for bioenergy cabins and collagen products. EUDA plans to integrate these products into its offerings to target chronic conditions and tap into Southeast Asia's growing healthcare market.
